Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04354701 · ClinicalTrials.gov registry record

COVID-19 and Cancer Consortium Registry

A clinical trial of COVID-19 and Invasive Malignancy (Any Type), sponsored by Vanderbilt-Ingram Cancer Center.

Active
Registry status
19,275
Enrollment target
1
Study location

NCT04354701 is a study of COVID-19 and Invasive Malignancy (Any Type) that is active but no longer recruiting, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 19,275 participants, below the 55,120-participant average among 203 other COVID-19 trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04354701, a study of COVID-19 and Invasive Malignancy (Any Type), is active but no longer recruiting, sponsored by Vanderbilt-Ingram Cancer Center.

ACTIVE NOT RECRUITING
Registry status
19,275 participants
Enrollment target
1
Study location

Study Summary

In this study we will collect granular information on cancer patients infected with COVID-19, as rapidly as possible. The mechanism for collection of this information is a de-identified centralized registry housed at Vanderbilt University Medical Center, with data donations from internal and external health care professionals.

Conditions Studied

COVID-19 Invasive Malignancy (Any Type)

Interventions

  • OTHER Web-based REDCap survey

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 19,275 participants
Start Date 2020-03-17
Est. Completion 2029-12

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04354701

The ClinicalTrials.gov registry entry for NCT04354701 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 19,275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,120-participant average among 203 other COVID-19 trials with a reported enrollment target (65% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Web-based REDCap survey is the first listed.

NCT04354701 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04354701 about?

NCT04354701 is a clinical study titled "COVID-19 and Cancer Consortium Registry". In this study we will collect granular information on cancer patients infected with COVID-19, as rapidly as possible. The mechanism for collection of this information is a de-identified centralized registry housed at Vanderbilt University Medical Center, with data donations from internal and externa...

What is the current status of trial NCT04354701?

This trial is currently active not recruiting. The enrollment target is 19,275 participants. The study started on 2020-03-17. Estimated completion is 2029-12.

What conditions does trial NCT04354701 study?

This clinical trial studies the following conditions: COVID-19, Invasive Malignancy (Any Type).

What interventions are being tested in trial NCT04354701?

The interventions under investigation include: Web-based REDCap survey (OTHER).

Who is sponsoring clinical trial NCT04354701?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04354701 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

COVID-19

All registered trials for this condition

Invasive Malignancy (Any Type)

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.